Novel Mouse Models of Bladder Cancer Identify a Prognostic Signature Associated with Risk of Disease Progression.

Autor: Park S; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York., Rong L; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York., Owczarek TB; Department of Urology, Columbia University Irving Medical Center, New York, New York., Bernardo MD; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York., Shoulson RL; Institute of Comparative Medicine, Columbia University, New York, New York., Chua CW; Department of Urology, Columbia University Irving Medical Center, New York, New York.; Department of Medicine, Columbia University Irving Medical Center, New York, New York.; Department of Genetics & Development, Columbia University Irving Medical Center, New York, New York.; Department of Systems Biology, Columbia University Irving Medical Center, New York, New York., Kim JY; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York., Lankarani A; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York., Chakrapani P; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York., Syed T; Department of Urology, Columbia University Irving Medical Center, New York, New York.; Department of Medicine, Columbia University Irving Medical Center, New York, New York.; Department of Genetics & Development, Columbia University Irving Medical Center, New York, New York.; Department of Systems Biology, Columbia University Irving Medical Center, New York, New York.; Department of Biological Sciences, Columbia University, New York, New York., McKiernan JM; Department of Urology, Columbia University Irving Medical Center, New York, New York.; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York., Solit DB; Departments of Human Oncology and Pathogenesis and Medicine, Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York.; Weill Medical College, Cornell University, New York, New York., Shen MM; Department of Urology, Columbia University Irving Medical Center, New York, New York.; Department of Medicine, Columbia University Irving Medical Center, New York, New York.; Department of Genetics & Development, Columbia University Irving Medical Center, New York, New York.; Department of Systems Biology, Columbia University Irving Medical Center, New York, New York.; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York., Al-Ahmadie HA; Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York., Abate-Shen C; Department of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York. cabateshen@columbia.edu.; Department of Urology, Columbia University Irving Medical Center, New York, New York.; Department of Systems Biology, Columbia University Irving Medical Center, New York, New York.; Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York.

Publikováno v: Cancer research [Cancer Res] 2021 Oct 15; Vol. 81 (20), pp. 5161-5175. Date of Electronic Publication: 2021 Sep 01.

Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).

Autor: Shoulson RL; Institute of Comparative Medicine, Columbia University, New York, New York, USA. rs2752@columbia.edu., Stark RL; Division of Neonatology, Columbia University, New York, New York, USA., Garland M; Division of Neonatology, Columbia University, New York, New York, USA.

Publikováno v: Journal of the American Association for Laboratory Animal Science : JAALAS [J Am Assoc Lab Anim Sci] 2014 Nov; Vol. 53 (6), pp. 708-16.